Ting Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ting Guo has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Yingying Qin
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China
17 shared publications Keyan Xu
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong 250012, China
7 shared publicationsYingying Qin
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China
7 shared publicationsBingying Xu
6 shared publicationsHanni Ke
Center for Reproductive Medicine, Shandong University , Jinan, China
6 shared publicationsShidou Zhao
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China; Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan 250012, China
6 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Wolters Kluwer Health in Chinese Medical Journal
Age-specific anti-Müllerian hormone reference values using an ultrasensitive assay: Associations with ovarian aging and menopausal transition symptoms
Background: Accurately assessing ovarian aging remains a critical challenge in women’s health, particularly during the late reproductive stage and menopausal transition. Anti-Müllerian hormone (AMH) is widely used to reflect ovarian reserve, but its application in midlife women is limited by the lack of standardized age-specific reference values and poor sensitivity of conventional assays at low AMH levels. This study aimed to establish age-specific AMH reference percentiles in midlife Chinese women using an ultrasensitive assay and to evaluate their clinical relevance for assessing ovarian aging during the menopausal transition. Methods: We analyzed serum AMH levels in 10,543 Chinese women aged 34–56 years from a nationally representative cohort using a highly sensitive assay (limit of detection: 0.003 ng/mL). Generalized additive models for location, scale, and shape were used to construct age-specific AMH percentiles. Associations with longitudinal AMH decline ( n = 2521), perimenopausal symptoms (PMSs) (via modified Kupperman index), and menopausal status ( n = 422 postmenopausal women) were evaluated. Results: The ultrasensitive assay enabled detection of AMH levels in most women aged 44–49 years and distinguished postmenopausal from premenopausal women (median 0.043 vs . 0.187 ng/mL, P < 0.001). Area under the curve for menopause diagnosis was 0.72 (cutoff = 0.0055 ng/mL). Age-specific AMH percentiles were established based on a nationwide cross-sectional cohort of 10,543 women, providing the first standardized reference for late reproductive stages. In the longitudinal cohort, women with baseline AMH below the 10th percentile experienced faster decline before age 40. Among women aged 35–55 years, lower AMH percentiles were associated with more severe PMSs (β = 0.12), particularly vasomotor symptoms (VMSs). Conclusions: Ultrasensitive AMH profiling enables the construction of age-specific reference percentiles applicable to women in late reproductive stages. This framework enhances the clinical utility of AMH for individualized fertility counseling, PMS management, and menopausal status assessment.
- 17 August 2026
- Published by Wolters Kluwer Health in Chinese Medical Journal
Open AccessAge-specific anti-Müllerian hormone reference values using an ultrasensitive assay: Associations with ovarian aging and menopausal transition symptoms
Background: Accurately assessing ovarian aging remains a critical challenge in women’s health, particularly during the late reproductive stage and menopausal transition. Anti-Müllerian hormone (AMH) is widely used to reflect ovarian reserve, but its application in midlife women is limited by the lack of standardized age-specific reference values and poor sensitivity of conventional assays at low AMH levels. This study aimed to establish age-specific AMH reference percentiles in midlife Chinese women using an ultrasensitive assay and to evaluate their clinical relevance for assessing ovarian aging during the menopausal transition. Methods: We analyzed serum AMH levels in 10,543 Chinese women aged 34–56 years from a nationally representative cohort using a highly sensitive assay (limit of detection: 0.003 ng/mL). Generalized additive models for location, scale, and shape were used to construct age-specific AMH percentiles. Associations with longitudinal AMH decline ( n = 2521), perimenopausal symptoms (PMSs) (via modified Kupperman index), and menopausal status ( n = 422 postmenopausal women) were evaluated. Results: The ultrasensitive assay enabled detection of AMH levels in most women aged 44–49 years and distinguished postmenopausal from premenopausal women (median 0.043 vs . 0.187 ng/mL, P < 0.001). Area under the curve for menopause diagnosis was 0.72 (cutoff = 0.0055 ng/mL). Age-specific AMH percentiles were established based on a nationwide cross-sectional cohort of 10,543 women, providing the first standardized reference for late reproductive stages. In the longitudinal cohort, women with baseline AMH below the 10th percentile experienced faster decline before age 40. Among women aged 35–55 years, lower AMH percentiles were associated with more severe PMSs (β = 0.12), particularly vasomotor symptoms (VMSs). Conclusions: Ultrasensitive AMH profiling enables the construction of age-specific reference percentiles applicable to women in late reproductive stages. This framework enhances the clinical utility of AMH for individualized fertility counseling, PMS management, and menopausal status assessment.
- Open Access
- 26 June 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Social isolation and loneliness associate with early menopause and mortality in women: a UK Biobank cohort study
Reproductive aging is an emerging public health priority amid demographic shifts. Early menopause (EM), indicative of accelerated reproductive aging, is associated with an elevated risk of premature mortality. While social isolation (SI) and loneliness (LO) are established psychosocial determinants of health, their associations with EM and their combined effects with menopausal status on mortality risk remain unquantified. This study investigated the associations of SI and LO with EM and all-cause mortality. This study included 79,578 Caucasian women from the UK Biobank cohort, of whom 6,778 experienced EM (menopause at age 40-45) and 72,800 experienced normal menopause (NM, age 46-55). SI (score: 0, 1, ≥2) was derived from three indicators: living arrangement, frequency of social contact, and participation in social activities; LO (score 0-2) was assessed based on self-reported loneliness and frequency of confiding in someone close. Multivariable-adjusted models were used to evaluate the odds of EM. All-cause mortality risk was assessed using Cox proportional hazards models, stratified by menopause status. Higher levels of SI and LO were independently associated with an increased prevalence of EM (e.g. SI ≥ 2: OR = 1.09, 95% CI 1.00-1.20; LO = 2: OR = 1.13, 95% CI 1.02-1.25). Critically, the detrimental impact of social adversity on survival was significantly greater in women with EM compared to those with NM. After full adjustment, women with EM and SI index ≥ 2 had a 55% increased mortality risk (HR = 1.55, 95% CI 1.21-1.99), whereas the risk increase for women with NM was 17% (HR = 1.17, 95% CI 1.07-1.28). A similar pattern was observed for LO (e.g. LO = 2, EM: HR = 1.42, 95% CI 1.07-1.88 vs. NM: HR = 1.14, 95% CI 1.02-1.27). Moreover, Kaplan-Meier curves showed a progressively wider survival gap between EM and NM as SI/LO levels increased. Lower SI and LO were associated with lower EM-related excess mortality. SI and LO were associated with EM and premature mortality. Women with EM are especially vulnerable to the negative effects of social adversity. Integrating psychological and social support into menopause care is essential, and reducing SI and LO may promote healthier aging. NA.
- 26 June 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Open AccessSocial isolation and loneliness associate with early menopause and mortality in women: a UK Biobank cohort study
Reproductive aging is an emerging public health priority amid demographic shifts. Early menopause (EM), indicative of accelerated reproductive aging, is associated with an elevated risk of premature mortality. While social isolation (SI) and loneliness (LO) are established psychosocial determinants of health, their associations with EM and their combined effects with menopausal status on mortality risk remain unquantified. This study investigated the associations of SI and LO with EM and all-cause mortality. This study included 79,578 Caucasian women from the UK Biobank cohort, of whom 6,778 experienced EM (menopause at age 40-45) and 72,800 experienced normal menopause (NM, age 46-55). SI (score: 0, 1, ≥2) was derived from three indicators: living arrangement, frequency of social contact, and participation in social activities; LO (score 0-2) was assessed based on self-reported loneliness and frequency of confiding in someone close. Multivariable-adjusted models were used to evaluate the odds of EM. All-cause mortality risk was assessed using Cox proportional hazards models, stratified by menopause status. Higher levels of SI and LO were independently associated with an increased prevalence of EM (e.g. SI ≥ 2: OR = 1.09, 95% CI 1.00-1.20; LO = 2: OR = 1.13, 95% CI 1.02-1.25). Critically, the detrimental impact of social adversity on survival was significantly greater in women with EM compared to those with NM. After full adjustment, women with EM and SI index ≥ 2 had a 55% increased mortality risk (HR = 1.55, 95% CI 1.21-1.99), whereas the risk increase for women with NM was 17% (HR = 1.17, 95% CI 1.07-1.28). A similar pattern was observed for LO (e.g. LO = 2, EM: HR = 1.42, 95% CI 1.07-1.88 vs. NM: HR = 1.14, 95% CI 1.02-1.27). Moreover, Kaplan-Meier curves showed a progressively wider survival gap between EM and NM as SI/LO levels increased. Lower SI and LO were associated with lower EM-related excess mortality. SI and LO were associated with EM and premature mortality. Women with EM are especially vulnerable to the negative effects of social adversity. Integrating psychological and social support into menopause care is essential, and reducing SI and LO may promote healthier aging. NA.
- Open Access
- 1 May 2026
- Published by KEAI Publishing in Fundamental Research
- Vol. 6 (3) , 1504-1507
Genetic variants in the homologous recombination pathway as common risk for premature ovarian insufficiency and ovarian cancer
- 1 May 2026
- Published by KEAI Publishing in Fundamental Research
- Vol. 6 (3) , 1504-1507
Open AccessGenetic variants in the homologous recombination pathway as common risk for premature ovarian insufficiency and ovarian cancer
- Open Access
- 15 April 2026
- Published by Elsevier in Science Bulletin
- Vol. 71 (10) , 2433-2437
Menopause status and modifiable risk factors for early menopause in China: a nationwide cross-sectional study on geographical disparities
- 15 April 2026
- Published by Elsevier in Science Bulletin
- Vol. 71 (10) , 2433-2437
Open AccessMenopause status and modifiable risk factors for early menopause in China: a nationwide cross-sectional study on geographical disparities
- 17 December 2025
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 53 (4) , 615-629
MEI4 variations drive female reproductive disorders via impaired oocyte abundance and developmental potential
- 17 December 2025
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 53 (4) , 615-629
MEI4 variations drive female reproductive disorders via impaired oocyte abundance and developmental potential
- Open Access
- 31 July 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (8) , 1548-1567
Stress granule clearance mediated by V-ATPase-interacting protein NCOA7 mitigates ovarian aging
Reproductive longevity is essential for female fertility and healthy aging; however, the role of stress response, especially stress granule accumulation, in ovarian aging remains elusive and interventions are lacking. Here, we identified deleterious mutations and decreased expression of NCOA7, a stress-response protein related to granulosa cell senescence in women with physiological and pathological ovarian aging. NCOA7 deletion accelerates oxidative stress-related cellular senescence, ovarian aging and fecundity decline in mice. Mechanistically, NCOA7 partitions into the stress granule containing G3BP1–V-ATPase and facilitates autophagic degradation of stress granules to relieve stress. Boosting granulophagy with rapamycin or lipid nanoparticle-based mRNA delivery of NCOA7 accelerates stress granule clearance, alleviating cellular senescence in human granulosa cells and delaying ovarian aging in mice. This study depicts a mechanism for ovarian resilience to stress and provides potential targets for therapeutic strategies to alleviate ovarian aging.
- 31 July 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (8) , 1548-1567
Open AccessStress granule clearance mediated by V-ATPase-interacting protein NCOA7 mitigates ovarian aging
Reproductive longevity is essential for female fertility and healthy aging; however, the role of stress response, especially stress granule accumulation, in ovarian aging remains elusive and interventions are lacking. Here, we identified deleterious mutations and decreased expression of NCOA7, a stress-response protein related to granulosa cell senescence in women with physiological and pathological ovarian aging. NCOA7 deletion accelerates oxidative stress-related cellular senescence, ovarian aging and fecundity decline in mice. Mechanistically, NCOA7 partitions into the stress granule containing G3BP1–V-ATPase and facilitates autophagic degradation of stress granules to relieve stress. Boosting granulophagy with rapamycin or lipid nanoparticle-based mRNA delivery of NCOA7 accelerates stress granule clearance, alleviating cellular senescence in human granulosa cells and delaying ovarian aging in mice. This study depicts a mechanism for ovarian resilience to stress and provides potential targets for therapeutic strategies to alleviate ovarian aging.
- Open Access
- 25 July 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1104
Biallelic BRCA2 variants induce premature ovarian insufficiency by impaired meiotic homologous recombination
The DNA damage response plays a pivotal role in ovarian aging. Breast cancer susceptibility gene 2 (BRCA2), which participates in homologous recombination (HR), is a key regulator of natural menopause. Rare BRCA2 variants have been identified in patients with premature ovarian insufficiency (POI). However, the underlying molecular mechanisms are not well understood. Using a viable mouse model, Brca2c.68-1G>C/c.4384-4394del, carrying compound heterozygous variants mirroring the ones identified in a POI pedigree, we illustrated the essential role of BRCA2 in primordial follicle pool establishment. Germline deficiency of BRCA2 did not affect primordial germ cell (PGC) proliferation but impaired the recruitment of RAD51 and DMC1 to programmed DNA double-strand breaks (DSBs) during meiotic HR, causing postnatal oocyte depletion. Moreover, Brca2c.68-1G>C/c.4384-4394del mice presented increased tumor susceptibility. These findings confirmed the pathogenicity of BRCA2 biallelic variants in POI, revealing the dual impact on germ cell development and somatic cancer risk, underscoring the necessity of tumor surveillance in POI patients with BRCA2 mutations.
- 25 July 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1104
Open AccessBiallelic BRCA2 variants induce premature ovarian insufficiency by impaired meiotic homologous recombination
The DNA damage response plays a pivotal role in ovarian aging. Breast cancer susceptibility gene 2 (BRCA2), which participates in homologous recombination (HR), is a key regulator of natural menopause. Rare BRCA2 variants have been identified in patients with premature ovarian insufficiency (POI). However, the underlying molecular mechanisms are not well understood. Using a viable mouse model, Brca2c.68-1G>C/c.4384-4394del, carrying compound heterozygous variants mirroring the ones identified in a POI pedigree, we illustrated the essential role of BRCA2 in primordial follicle pool establishment. Germline deficiency of BRCA2 did not affect primordial germ cell (PGC) proliferation but impaired the recruitment of RAD51 and DMC1 to programmed DNA double-strand breaks (DSBs) during meiotic HR, causing postnatal oocyte depletion. Moreover, Brca2c.68-1G>C/c.4384-4394del mice presented increased tumor susceptibility. These findings confirmed the pathogenicity of BRCA2 biallelic variants in POI, revealing the dual impact on germ cell development and somatic cancer risk, underscoring the necessity of tumor surveillance in POI patients with BRCA2 mutations.
- Open Access
- 30 May 2025
- Published by BMJ in Gynecology and Obstetrics Clinical Medicine
- Vol. 5 (2) , e000208
Bi-allelic variation ofFANCJ(BRIP1) identified in premature ovarian insufficiency
Objective: Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such asFANCAandFANCM. FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve.FANCJencodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygousFANCJmissense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution ofFANCJvariants in POI, we reported a rare homozygousFANCJstart-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies.Methods: The loss-of-function (LoF) variants ofFANCJwere screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein.Results: Through the variation screening, a bi-allelic variant ofFANCJ(NM_032043.3:c.1A>G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway.Conclusion: Our findings provide further genetic evidence of theFANCJvariant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.
- 30 May 2025
- Published by BMJ in Gynecology and Obstetrics Clinical Medicine
- Vol. 5 (2) , e000208
Open AccessBi-allelic variation ofFANCJ(BRIP1) identified in premature ovarian insufficiency
Objective: Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such asFANCAandFANCM. FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve.FANCJencodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygousFANCJmissense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution ofFANCJvariants in POI, we reported a rare homozygousFANCJstart-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies.Methods: The loss-of-function (LoF) variants ofFANCJwere screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein.Results: Through the variation screening, a bi-allelic variant ofFANCJ(NM_032043.3:c.1A>G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway.Conclusion: Our findings provide further genetic evidence of theFANCJvariant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.